Ensuring PBM Competition Act
This bill prohibits the U.S. Department of Health and Human Services from entering or renewing contracts with Medicare Part D drug plan sponsors that have contracts with pharmacy benefits managers (PBMs) owning or controlling pharmacies. It directly affects Medicare Part D plan sponsors and PBMs with financial ties to pharmacies, banning such sponsor-PBM contracts starting 5 years after enactment (with a possible 2-year delay). The key mechanism requires the Secretary to exclude these sponsors from Medicare drug plans, aiming to reduce conflicts of interest where PBMs control both pharmacy networks and drug pricing.
Bill status
in committee
1 of 4 stages cleared
Introduction
Dec 2023
Committee Review
Floor Vote
President
Introduced Dec 15, 2023
Last action Dec 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
House · Referred to committee
Referred to the Subcommittee on Health.
Dec 22, 2023
House · Referred to committee
Referred to the Subcommittee on Health.
Dec 15, 2023
House · Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 15, 2023
House · Introduced
Introduced in House
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Claudia Tenney
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6844
Scope: US
Hi! I can help you understand HR 6844. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline